Transcriptomics

Dataset Information

0

RNA-seq of cardiomyocytes exposed to glucose deprivation with or without empagliflozin treatment


ABSTRACT: Glucose-lowering drugs sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of serious heart failure events, regardless of diabetes status, but the underling mechanism of this cardioprotective benefit is unknown. Here, we performed RNA-seq screening in cardiomyocytes to determine the potential cardioprotective mechanism of empagliflozin (EMPA).

ORGANISM(S): Rattus norvegicus

PROVIDER: GSE200598 | GEO | 2022/12/12

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-11-14 | GSE247061 | GEO
2020-03-19 | GSE132781 | GEO
2024-09-13 | GSE255933 | GEO
2023-11-22 | GSE243752 | GEO
2023-11-14 | GSE247062 | GEO
2022-12-31 | E-MTAB-11253 | biostudies-arrayexpress
2023-03-22 | GSE202031 | GEO
| PRJNA825500 | ENA
2023-03-10 | PXD036090 | Pride
2022-12-31 | GSE191046 | GEO